Aromatase Inhibitor class drugs

2 results

  • Arimidex

    (Anastrozole)
    ANI Pharmaceuticals, Inc.
    Usage: ARIMIDEX is indicated for adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for first-line and second-line treatment of hormone receptor-positive or unknown locally advanced and metastatic breast cancer, particularly after disease progression on tamoxifen therapy.

  • Aromasin

    (exemestane)
    Pharmacia & Upjohn Company LLC
    Usage: AROMASIN is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer after two to three years of tamoxifen, completing a total of five years of therapy. It is also used to treat advanced breast cancer in postmenopausal women progressing after tamoxifen.